Home
>
National Drug Code (NDC)
>
Pepto Relief
Pepto Relief - 17714-045-30 - (Bismuth subsalicylate)
Drug Information of Pepto Relief
| Product NDC: | 17714-045 |
| Proprietary Name: | Pepto Relief |
| Non Proprietary Name: | Bismuth subsalicylate |
| Active Ingredient(s): | 262 mg/1 & nbsp; Bismuth subsalicylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pepto Relief
| Product NDC: | 17714-045 |
| Labeler Name: | Advance Pharmaceutical Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part335 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20020109 |
Package Information of Pepto Relief
| Package NDC: | 17714-045-30 |
| Package Description: | 30 TABLET, CHEWABLE in 1 BOTTLE (17714-045-30) |
NDC Information of Pepto Relief
| NDC Code | 17714-045-30 |
| Proprietary Name | Pepto Relief |
| Package Description | 30 TABLET, CHEWABLE in 1 BOTTLE (17714-045-30) |
| Product NDC | 17714-045 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Bismuth subsalicylate |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 20020109 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Advance Pharmaceutical Inc. |
| Substance Name | BISMUTH SUBSALICYLATE |
| Strength Number | 262 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
